Document Type : Research Paper

Authors

University of Anbar / College of Science

10.37652/juaps.2015.124365

Abstract

This work study the different changes of blood disease with hepatitis B and compared with control group . Blood samples taken from One hundred with Hepatitis B , and compared with One hundred blood sample taken from healthy people to study :count total and differential white blood cells , Red blood cells count , Assess the concentration Hemoglobin , Packed Cells Volume , Erythrocytes Sedimentation Rate , Estimate number of platelets and the RBCs Indices . This work showed significant differences in WBCs differential as found high moral in the percentage of lymphocytes and a decrease in the proportion of cells Neutrophils and Monocytes and the proportion cells of the Basophisls nor Eosinophils . there was no significant differences in the total number of WBC between patients and control. Also recorded a significant rise in the value of ESR test. While no significant differences were recorded between the two groups of patients and control for the total number of red blood cells, platelets, concentration Hemoglobin and the PCV test, as well as indicators of red blood cells.

Main Subjects

1-   AL-Shook, M et al. (2008) Immunological Changes   Associated with Chronic Hepatitis B Virus Infection.
2-   Al-Barzinji, R.  and Hiwa A. (2010), Estimation of Immunoglobulin (IgG and IgM) in Hepatitis B Virus Infected Patients and Individuals Vaccinated with Recombinant HB Vaccine, The Iraqi Postgraduate Medical Journal 9(3):257-261.
3-   Hou، J. et al. (2005) Epidemiology and prevention of Hepatitis B virus. Int. J. Med. Sc. 2:50–57.
4-   Al-Shamary, A. (2004 ) HBV Infection :Serological Markers and Antibody Protective Level Among  Iraqi Vaccinated and Un Vaccinated Population، Ph.D. thesis، College of Medicine،University of  Baghdad.
5-   Al-jumaily, H. et al. (2013)  Seroconversion of Anti-HBs alone among certain high risk groups in Al-Ramadi City, Western Iraq. International Research Journal of Medicine and Medical Sciences 1(2): 56-63.
6-   Feldman, M. et al. (2006) Gastrointestinal and Liver Disease.8thed. Canada, 3 :1639-1687.
7-    Lisman, T. and Robert J. (2013) Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. American Society of Hematology, Washington.
8-   Friedman L. et al. (2012) Handbook of liver diseases. 3rd  ed. Library of Congress Cataloging-in-Publication Data.
9-   Fox S. (2011) Human Physiology, 12th ed. McGraw-Hill.
10-    Kuter D.، Begley C. (2002) Recombinant human Thrombopoietin : basic biology and evaluation of clinical studies. Blood ;100:3457 – 69.
11-    Lewis, S. et al. (2006) Daci and Lewis practical hematology. 10th  ed. Churchill Livingston. USA.
12-    Powers, L.W. (1989) Diagnostic hematology : clinical and technical principles. C. V. Mosby comp. Philadelphia  USA.
13-    Vassilopoulos, D. et al. (2008). Cellular immune responses in hepatitis B virus e antigen negative chronic hepatitis B. J Viral Hepat.14(8).352-357.
14-    Hui Ma, et al. (2008) Clinical features and survival in Chinese patients with hepatitis B e antigen-negative hepatitis B virus-related cirrhosis، Journal of Gastroenterology and Hepatology 23 1250–1258.
15-    Frasier, T. (2008) complete blood count in primary care. Bpac.org.nz.
16-    Huang، Chien-Fu, et al. (2006) The Immune Response Induced by Hepatitis B Virus Princi09pal Antigens، The Chinese Society of Immunology 3(2):97-106 
17-    Saadeh, C. (1998). The erythrocyte sedimentation rate: old and new clinical applications. South Med J. 3:220-225.
18-    Amjad, M. et al. (2011) Epidemiological   Study of Viral Hepatitis  B in Different  Localities  of Faisalabad, Global  Journal  of Biotechnology   & Biochemistry  6 (1):  36-40.
19-    Provan، D. (2007)، ABC of Clinical Haematology, 3rd  Ed.، Blackwell Publishing Ltd.
20-    Lin، C. (2006)  Selenium,  Iron, Copper, and Zinc Levels and Copper-to-Zinc  Ratios in Serum  of Patients  at Different Stages  of Viral Hepatic Diseases. Biological  Trace Element Research 109:15-23.